C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2001
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077321A2 Identification of a human gaba transporter
10/18/2001	WO2001077317A1 Method of amplifying nucleic acid by using double-stranded nucleic acid as template
10/18/2001	WO2001077315A1 Signal sequence trapping
10/18/2001	WO2001077312A1 A transformant for screening of inhibitors for human immunodeficiency virus
10/18/2001	WO2001077300A2 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
10/18/2001	WO2001077297A1 Specific inhibitors of ribosome recycling factor (rrf)
10/18/2001	WO2001077295A1 Mutant bank
10/18/2001	WO2001077283A1 Utilization of invertebrate learning for flexible and sensitive monitoring and identification of chemicals
10/18/2001	WO2001077178A2 Compositions and methods for detection of von willebrand's disease
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077172A2 Non-endogenous, constitutively activated known g protein-coupled receptors
10/18/2001	WO2001077170A2 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077164A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
10/18/2001	WO2001077150A2 Serine-threonine kinase
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077140A2 Measurement of nutrient uptake in cells and methods based thereon
10/18/2001	WO2001077132A2 Haplotypes of the il5 gene
10/18/2001	WO2001077131A2 Haplotypes of the bglap gene
10/18/2001	WO2001077130A2 Haplotypes of the apoa2 gene
10/18/2001	WO2001077129A2 Haplotypes of the apoc1 gene
10/18/2001	WO2001077128A2 Haplotypes of the slc5a3 gene
10/18/2001	WO2001077127A2 Haplotypes of the apoc4 gene
10/18/2001	WO2001077126A2 Haplotypes of the hsd3b2 gene
10/18/2001	WO2001077125A2 Haplotypes of the ccr5 gene
10/18/2001	WO2001077124A2 Haplotypes of the apoa4 gene
10/18/2001	WO2001076620A2 Use of vegf and homologues to treat neuron disorders
10/18/2001	WO2001076451A2 Diagnosis of diseases associated with metabolism
10/18/2001	WO2001059450A8 Cells expressing zinc finger protein for drug discovery
10/18/2001	WO2001048242A9 Methods for amplifying and detecting multiple polynucleotides on a solid phase support
10/18/2001	WO2001038352A3 Methods of inhibiting metastasis
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001034847A3 Flow cell for synthesis of arrays of dna probes and the like
10/18/2001	WO2001031015A3 36p6d5: secreted tumor antigen
10/18/2001	WO2001027318A3 Reverse transcriptase assay
10/18/2001	WO2001027315A3 For substances acting on msk1 or msk2
10/18/2001	WO2001025795A3 One step test to detect antimicrobial residues in eggs
10/18/2001	WO2001025245A3 Drug target isogenes: polymorphisms in the death-associated protein 6 gene
10/18/2001	WO2001025194A3 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
10/18/2001	WO2001023620A3 Arrays with modified oligonucleotide and polynucleotide compositions
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof
10/18/2001	WO2001023411A3 Incorporation of modified nucleotides by archaeon dna polymerases and related methods
10/18/2001	WO2001022090A9 Method for identifying compounds useful in the therapy of bone disorders
10/18/2001	WO2001021825A3 Novel enzymes which dehydrate glycerol
10/18/2001	WO2001020004A3 Protein phosphatase and kinase proteins
10/18/2001	WO2001007640A3 Method for detecting single nucleotide polymorphisms
10/18/2001	WO2000071682A3 Crystal structure data of cysteinprotease gingipain r
10/18/2001	WO2000066769A3 System and method for screening of nasopharyngeal carcinoma
10/18/2001	WO2000055361A3 Method for identifying organisms by means of comparative genetic analysis and primers and hybridisation probes for carrying out this method
10/18/2001	WO2000046394A9 Tryptophan synthase as a site of herbicide action
10/18/2001	WO2000046236A9 Novel rgs-containing molecules and uses thereof
10/18/2001	WO2000044782A9 Ewing's tumour antigen, nucleic acid and antibodies
10/18/2001	WO2000043498A9 Human liver progenitors
10/18/2001	US20010032342 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase for improvement and optimization of plant phenotypes
10/18/2001	US20010032337 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example
10/18/2001	US20010031860 Serum marker, immunohistological marker to detect prostate cancer tissues
10/18/2001	US20010031750 Administering an analgesic of an inhibitor of cyclic guanosine monophosphate dependent protein kinase such as rp-8-((4-chlorophenyl)thio)-guanosine 3',5'-cyclic monophosphothioate triethylamine
10/18/2001	US20010031739 Method and kit for quantitating genomic DNA damage and repair capicity
10/18/2001	US20010031504 Biochip and method for fabricating the same
10/18/2001	US20010031492 Assay reagent
10/18/2001	US20010031485 Nucleic acid coding for fusion protein which binds receptor; internalized by endocytosis; inhibits ribosomes and angiogenesis; therapy for tumors, metastasis, eye disorders, chronic inflammation and ischemic injuries
10/18/2001	US20010031483 Synthesizing polynucleotides employing releasable primers with specific releasing enzymes
10/18/2001	US20010031479 Method and reagent for determination of cholesterol in remant-like particles
10/18/2001	US20010031478 Protease inhibitor assay
10/18/2001	US20010031477 Malonyl/acyl carrier protein substrate labeled with biotin incorporates radiolabeled acyl/malonyl thioester upon contact with enzyme; complexes with avidin coated scintillant support system
10/18/2001	US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease
10/18/2001	US20010031474 Chimeric neuropeptide Y receptors
10/18/2001	US20010031472 Moiety of at least two analyte residues linked to reporter group detectable by mass spectrometry for analysis of proteins/peptides, nucleic acids/oligonucleotides, carbohydrates etc.
10/18/2001	US20010031471 Labeled with intercalated fluorescent dye; complex with RNA transcription product induces change in fluorescence; public hygiene; food poisoning; low temperature detection
10/18/2001	US20010031470 Using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined nucleic acid; detection of single nucleotide polymorphisms, speciation, viral load, genotyping
10/18/2001	US20010031469 Allows detection of post-translationally modified proteins; distinguishes molecular activity profiles of normal cells from pathological cells, or of two different protein or enzyme samples; cancer prognosis
10/18/2001	US20010031468 Contacting tagged affinity ligands such as antibodies with a sample to produce a binding complex between ligands and target analytes such as proteins, then hybridizing with a universal array of tag complements; proteomics
10/18/2001	US20010031467 By contacting with first targeting element which binds specifically to the sequence of interest, attaching a separation group such as biotin to the targeting element, immobilizing to a substrate and removing immobilized complex
10/18/2001	US20010031464 Multihued labels
10/18/2001	US20010031461 Potentiating a cell for sensitivity to a heterologous polynucleotide; host cells can be immediately used in further experiments to determine the function of a heterologous gene, and for drug screening
10/18/2001	US20010030290 Systems and methods for detection of labeled materials
10/18/2001	US20010029983 Microfabricated elastomeric valve and pump systems
10/18/2001	US20010029794 System and method for filling a substrate with a liquid sample
10/18/2001	DE10018465A1 Homogeneous test system for detecting splice reactions, useful for identifying splice modulators and diagnosis, includes splicable nucleic acid, labeled probes and non-gel detection system
10/18/2001	DE10018464A1 In vivo system for testing slice modulators, useful e.g. for diagnosis, comprises cellular system containing spliceable nucleic acid that generates detectable signal when spliced
10/18/2001	DE10017519A1 Detecting beer spoilage bacteria, from presence of the HorA membrane transporter responsible for hop resistance
10/18/2001	DE10016139A1 Verfahren zur Bestimmung von löslichem Fibrin A method for the determination of soluble fibrin
10/18/2001	DE10015821A1 New sensor, useful for detecting biopolymers, particularly protein or nucleic acid, comprises measuring changes in optical signal from trench coated with immobilized capture molecules
10/18/2001	DE10015818A1 Biosensor und Verfahren zum Ermitteln makromolekularer Biopolymere mit einem Biosensor Biosensor and method for determining macromolecular biopolymers with a biosensor
10/18/2001	DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system
10/18/2001	CA2659656A1 The use of vegf165 to treat neuron disorders
10/18/2001	CA2654413A1 Use of vegf and homologues to treat neuron disorders
10/18/2001	CA2442733A1 Diagnostic test for alzheimer's disease
10/18/2001	CA2416118A1 Method for identifying and isolating genome fragments with linkage disequilibrium
10/18/2001	CA2406448A1 Identification of a human gaba transporter
10/18/2001	CA2406366A1 Muir-torre-like syndrome infhit deficient mice
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405769A1 A method of distinguishing between living and dead cells using viability probes
10/18/2001	CA2405730A1 Serine-threonine kinase
10/18/2001	CA2405725A1 Identification of a novel dual specificity phosphataes
10/18/2001	CA2405687A1 Process for allele discrimation utilizing primer extension
10/18/2001	CA2405629A1 Methods for the survey and genetic analysis of populations
10/18/2001	CA2405311A1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	CA2405223A1 Diagnosis of schizophrenia by linkage of a polymorphic marker to a segment of chromosome 1q22 bordered by d1s2705 and d1s1679

1 ... 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 ... 3003